Fibromyalgia: A new treatment option for fibromyalgia

Robert M. Bennett

    Research output: Contribution to journalArticle

    3 Scopus citations

    Abstract

    The FDA’s approval of milnacipran reflects advances in the development of drugs aimed at modulating pain circuitry in fibromyalgia.

    Original languageEnglish (US)
    Pages (from-to)188-190
    Number of pages3
    JournalNature Reviews Rheumatology
    Volume5
    Issue number4
    DOIs
    StatePublished - Apr 2009

      Fingerprint

    ASJC Scopus subject areas

    • Rheumatology

    Cite this